3rd Immune Effector Cell Therapies in Multiple Myeloma Workshop
Building upon the success of prior workshops, the International Myeloma Society is happy to host the 3rd Immune Effector Cell Therapies in Multiple Myeloma Workshop to discuss various immune-based therapies in myeloma including CART cell clinical data and promising preclinical leads, review the latest correlative analyses exploring predictors of response and resistance mechanisms, evaluate uniform practices in managing patients with CRS and other complications, and discuss next-generation cell therapy strategies, including “off-the-shelf” allogeneic and NK-cell based approaches. This year we are also including a session on cell-engaging bispecific antibody-based approaches.
Thank you to our sponsors:
Platinum
Gold
Silver
Registration rates
| Registration Category | In Person Rate | Virtual Rate |
| Member | $425.00 | $0.00 |
| Non-Member | $525.00 | $100.00 |
| Non-Members in Training | $100.00 | $50.00 |
| Pharma Industry | $600.00 | $150.00 |
